Marshall Wace
AVXL icon

Marshall Wace’s Anavex Life Sciences AVXL Stock Holding History

Marshall Wace’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.3M Buy
889,523
+470,026
+112% +$1.39M ﹤0.01% 1781
2026
Q1 		$1.29M Buy
419,497
+237,307
+130% +$1.03M ﹤0.01% 2013
2025
Q4 		$649K Hold
182,190
– – ﹤0.01% 2134
2025
Q3 		$1.62M Hold
182,190
– – ﹤0.01% 1716
2025
Q2 		$1.68M Hold
182,190
– – ﹤0.01% 1643
2025
Q1 		$1.56M Buy
182,190
+41,071
+29% +$388K ﹤0.01% 1579
2024
Q4 		$1.52M Buy
+141,119
New +$1.09M ﹤0.01% 1552
2024
Q3 		– Sell
-39,351
Closed -$166K – 2497
2024
Q2 		$166K Buy
+39,351
New +$159K ﹤0.01% 2332
2023
Q4 		– Sell
-156,078
Closed -$1.02M – 2174
2023
Q3 		$1.02M Buy
156,078
+144,779
+1,281% +$1.15M ﹤0.01% 1498
2023
Q2 		$91.9K Sell
11,299
-36,401
-76% -$312K ﹤0.01% 2333
2023
Q1 		$409K Buy
47,700
+12,704
+36% +$127K ﹤0.01% 2181
2022
Q4 		$324K Buy
+34,996
New +$374K ﹤0.01% 2536
2022
Q3 		– Sell
-423,636
Closed -$4.24M – 3326
2022
Q2 		$4.24M Buy
423,636
+378,278
+834% +$3.58M 0.01% 1463
2022
Q1 		$558K Buy
+45,358
New +$558K ﹤0.01% 2725
2021
Q2 		– Sell
-163,087
Closed -$2.44M – 2639
2021
Q1 		$2.44M Buy
+163,087
New +$1.78M 0.01% 1219

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Marshall Wace's AVXL Position: Q2 2026 in Review

Marshall Wace increased its Anavex Life Sciences (AVXL) stake by 112% in Q2 2026, buying an estimated $1.39M and bringing the position to 889,523 shares worth $2.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1781.

Marshall Wace first reported a position in AVXL in Q1 2021 and has held it in 15 quarters since. The position peaked at $4.24M in Q2 2022. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Marshall Wace held 889,523 shares of Anavex Life Sciences worth $2.3M as of Q2 2026.
  • Marshall Wace bought 470,026 Anavex Life Sciences shares in Q2 2026, an estimated $1.39M.
  • Anavex Life Sciences made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1781 holding.
  • Marshall Wace first reported a position in Anavex Life Sciences in Q1 2021 and has held it in 15 quarters since.
  • Marshall Wace's Anavex Life Sciences position peaked at $4.24M in Q2 2022.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.